[go: up one dir, main page]

PE20080311A1 - Derivados de oxadiazol como agentes afines a receptores nicotinicos - Google Patents

Derivados de oxadiazol como agentes afines a receptores nicotinicos

Info

Publication number
PE20080311A1
PE20080311A1 PE2007000661A PE2007000661A PE20080311A1 PE 20080311 A1 PE20080311 A1 PE 20080311A1 PE 2007000661 A PE2007000661 A PE 2007000661A PE 2007000661 A PE2007000661 A PE 2007000661A PE 20080311 A1 PE20080311 A1 PE 20080311A1
Authority
PE
Peru
Prior art keywords
alkyl
oxadiazol
propyl
phenyl
amino
Prior art date
Application number
PE2007000661A
Other languages
English (en)
Inventor
Frank Teen Coppo
Emma S L Maskell
Sally Redshaw
John Skidmore
Robert William Ward
David Matthew Wilson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0610657.9A external-priority patent/GB0610657D0/en
Priority claimed from GB0619710A external-priority patent/GB0619710D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20080311A1 publication Critical patent/PE20080311A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

REFERIDA A UN DERIVADO DE OXADIAZOL DE FORMULA 8I), DONDE Q ES -(CH2)n-; n ES 3 O 4; Ra ES HIDROGENO O METILO; R1 ES -NR6COR7; R2 ES H, HALOGENO, ALQUILO C1-C6; R3 ES H, ALQUILO C1-C6, ALCOXI C1-C6, ENTRE OTROS; R4 Y R5 SON H, ALQUILO C1-C6, CICLOALQUILO C3-C6, ENTRE OTROS; R6 ES HIDROGENO; R7 ES ALQUILO C1-C5, CICLOALQUILO C3-C8, PIRIDILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 3-FLUORO-N-[4-(5-{[3-(4-MORFOLINIL)PROPIL]AMINO}-1,3,4-OXADIAZOL-2-IL)FENIL]BENZAMIDA, N-[3-(METILOXI)-4-(5-{[3-(4-MORFOLINIL)PROPIL]AMINO}-1,3,4-OXADIAZOL-2-IL)FENIL]CICLOPENTANO-CARBOXAMIDA, N-[4-(5-{[3-(DIETILAMINO)PROPIL]AMINO}-1,3,4-OXADIAZOL-2-IL)-3-(METILOXI)FENIL]-2,6-DIFLUOROBENZAMIDA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS TIENEN AFINIDAD POR LOS RECEPTORES NICOTINICOS, PARTICULARMENTE POR EL RECEPTOR NICOTINICO ALFA 7 Y SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES NEUROLOGICAS, TRASTORNOS PSIQUIATRICOS, TRASTORNOS RELACIONADOS CON EL DOLOR, ENTRE OTROS
PE2007000661A 2006-05-30 2007-05-28 Derivados de oxadiazol como agentes afines a receptores nicotinicos PE20080311A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0610657.9A GB0610657D0 (en) 2006-05-30 2006-05-30 Compounds
GB0619710A GB0619710D0 (en) 2006-10-05 2006-10-05 Compounds

Publications (1)

Publication Number Publication Date
PE20080311A1 true PE20080311A1 (es) 2008-05-23

Family

ID=38294122

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000661A PE20080311A1 (es) 2006-05-30 2007-05-28 Derivados de oxadiazol como agentes afines a receptores nicotinicos

Country Status (12)

Country Link
US (1) US20090105217A1 (es)
EP (1) EP2021331A1 (es)
JP (1) JP2009538865A (es)
KR (1) KR20090014223A (es)
AR (1) AR061196A1 (es)
AU (1) AU2007267170A1 (es)
BR (1) BRPI0711779A2 (es)
CA (1) CA2653771A1 (es)
EA (1) EA200870591A1 (es)
PE (1) PE20080311A1 (es)
TW (1) TW200811155A (es)
WO (1) WO2007138033A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0723719D0 (en) * 2007-12-04 2008-01-16 Glaxo Group Ltd Compounds
GB0723815D0 (en) * 2007-12-05 2008-01-16 Glaxo Group Ltd Compounds
TWI490214B (zh) * 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途
EP2323971B1 (en) * 2008-08-12 2012-05-09 F. Hoffmann-La Roche AG Salicylamide derivatives as nicotinic alpha 7 modulators
AU2009289329A1 (en) * 2008-09-02 2010-03-11 Neurosearch A/S Triazole derivatives and their use as nicotinic acetylcholine receptor modulators
WO2011079439A1 (en) * 2009-12-30 2011-07-07 Zannan Scitech Co., Ltd. Highly active metathesis catalysts selective for romp and rcm reactions
CN110709394B (zh) * 2017-03-31 2025-02-21 中美博瑞纳制药有限公司 可用作alcat1抑制剂的化合物
CN111960983A (zh) * 2020-08-31 2020-11-20 南通大学 一种n-甲基-3-(1-甲基吡咯烷-3-基)丙-1-胺及其合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60326894D1 (de) * 2002-09-30 2009-05-07 Neurosearch As 1,4-Diazabicycloalkanderivate, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
AR061196A1 (es) 2008-08-13
EP2021331A1 (en) 2009-02-11
BRPI0711779A2 (pt) 2011-11-29
AU2007267170A1 (en) 2007-12-06
WO2007138033A1 (en) 2007-12-06
CA2653771A1 (en) 2007-12-06
EA200870591A1 (ru) 2009-06-30
JP2009538865A (ja) 2009-11-12
TW200811155A (en) 2008-03-01
KR20090014223A (ko) 2009-02-06
US20090105217A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
PE20080311A1 (es) Derivados de oxadiazol como agentes afines a receptores nicotinicos
PE20141375A1 (es) Activadores de glucoquinasa
PE20090884A1 (es) Compuestos de indol como activadores de glucoquinasa
PE20090297A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogenesis
RU2008135690A (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
PE20090617A1 (es) Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa
PE20070189A1 (es) COMPUESTO DE AMINO-5-HETEROARILO (5 MIEMBROS) IMIDAZOLONA Y SU USO PARA MODULACION DE LA ß-SECRETASA
PE20142099A1 (es) Derivados de sulfonamida
PE20080925A1 (es) DERIVADOS DE PIRROLO[2,3-b]PIRIDINA COMO INHIBIDORES DE QUINASA, EN PARTICULAR INHIBIDORES IKK2 (O IKK BETA)
PE20040833A1 (es) Derivado de 1-aminociclohexano sustituidos en la posicion 4
PE20090160A1 (es) COMPUESTOS AMINO-5-[4-(DIFLUOROMETOXI)FENIL SUSTITUIDO]-5-FENILIMIDAZOLONA COMO INHIBIDORES DE ß-SECRETASA
PE20110028A1 (es) Derivados de isoxazol y su uso como potenciadores de los receptores metabotropicos de glutamato
PE20091201A1 (es) AMIDAS SUSTITUIDAS COMO INHIBIDORES DE LA TIROSINA QUINASA DE BRUTON (Btk)
PE20061150A1 (es) Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1)
PE20090641A1 (es) Amidas heterociclicas
PE20081229A1 (es) Antagonistas de receptor de orexina de diazepam sustituido
PE20020544A1 (es) Derivados de indolilmaleimida
PE20081378A1 (es) Derivados de 1,2,4-triazol como moduladores de mglur5
PE20110308A1 (es) 1,2,5-oxadiazoles como inhibidores de indolamina 2,3-dioxigenasa
PE20090477A1 (es) Derivados de oxazol como inhibidores de los canales de sodio
PE20200293A1 (es) Inhibidores pirazolicos de magl
PE20090435A1 (es) Inhibidores de tetrahidropiranocromeno de gamma secretasa
PE20081665A1 (es) Antagonistas del receptor de dopamina 2 de rapida disociacion
PE20090592A1 (es) Nuevos derivados de piperazina-amida
RU2008120850A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ

Legal Events

Date Code Title Description
FC Refusal